Giuseppe Vadalà

Dr. Giuseppe Vadalà

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
APAntonio Luca Maria Parlati
Antonio Luca Maria Parlati
ENErmanno Nardi
Ermanno Nardi
Vincenzo SucatoVincenzo Sucato
Vincenzo Sucato
CMCristina Madaudo
Cristina Madaudo
GLGiulio Leo
Giulio Leo
PPPasquale Perrone-Filardi
Pasquale Perrone-Filardi
The growing prevalence in the diagnosis of INOCA (Ischemia with Non-Obstructive Coronary Arteries), ANOCA (Angina with Non-Obstructive Coronary Arteries), and MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries) highlights the need to reassess their clinical relevance. Historically regarded as benign syndromes, emerging evidence suggests that these conditions may cause serious cardiovascular events and considerable long-term disability. Additionally, emerging studies suggest that non-obstructive coronary artery disease (CAD) may have a higher prevalence compared to traditional obstructive forms of CAD. This leads to the need to better clarify the underlying pathogenic mechanisms as well as the risk factors associated with these syndromes. This is precisely the aim of this review, which focuses on the complex and heterogeneous mechanisms underlying these syndromes as well as the associated risk factors. This review also sums up the diagnostic steps necessary to achieve an accurate diagnosis, along with the interventional and pharmacological approaches to be implemented in light of the latest evidence.

15 November 2020 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
MTMatteo Tebaldi
Matteo Tebaldi
SBSimone Biscaglia
Simone Biscaglia
AEAndrea Erriquez
Andrea Erriquez
CPCarlo Penzo
Carlo Penzo
CTCarlo Tumscitz
Carlo Tumscitz
Gianluca CampoGianluca Campo
Gianluca Campo

7 May 2020 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
GVGiuseppe Vadalà
Giuseppe Vadalà
AGAlfredo Ruggero Galassi
Alfredo Ruggero Galassi
RNRoberto Nerla
Roberto Nerla
AMAntonio Micari
Antonio Micari

8 March 2023 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
AAAlexandre Avran
Alexandre Avran
AZAndrea Zuffi
Andrea Zuffi
CGCecilia Gobbi
Cecilia Gobbi
AGAlessio Gasperetti
Alessio Gasperetti
MSMarco Schiavone
Marco Schiavone
CMCarlo Di Mario
Carlo Di Mario

26 February 2024 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
GVGiuseppe Vadalà
Giuseppe Vadalà
Vincenzo SucatoVincenzo Sucato
Vincenzo Sucato
FCFrancesco Costa
Francesco Costa
FCFausto Castriota
Fausto Castriota
RNRoberto Nerla
Roberto Nerla
AMAntonio Micari
Antonio Micari
Aims: To describe through emblematic images rare but clinically relevant carotid artery stenting complications that occurred at two high-volume centres for carotid artery stenting (CAS). Background: CAS is an alternative to carotid endarterectomy (CEA) for the treatment of carotid artery stenosis in patients judged to be at high risk for CEA. CAS complications range between 1 and 9% and are higher in older patients complaining of neurological symptoms at the time of presentation. Besides periprocedural or early-after-procedure stroke, which remains the true Achilles’ heel of CAS, other dramatic complications might compromise the clinical outcomes of this procedure. Methods: Five infrequent complications, out of more than 1000 CAS performed in the years 2016–2021, have been described. Results: Among CAS complications, acute carotid stent thrombosis, rescue retrieval of a disconnected distal cerebral embolic protection device, plaque prolapse after carotid stenting, cerebral hyperperfusion syndrome (CHS), and radial artery long sheath entrapment requiring surgical intervention were found to account for 0.3% of the total number of procedures performed by operators with high CAS volume. Conclusions: Unusual CAS complications may infrequently occur, even in hands of expert operators. To know how to deal with such complications might help interventionalists to improve CAS performance.

1 July 2024 in Circulation: Cardiovascular Quality and Outcomes
Verified
Journal Article
Closed access
Gianluca CampoGianluca Campo
Gianluca Campo
VGVincenzo Guiducci
Vincenzo Guiducci
JEJavier Escaned
Javier Escaned
RMRaul Moreno
Raul Moreno
GCGianni Casella
Gianni Casella
SBSimone Biscaglia
Simone Biscaglia
BACKGROUND: The FIRE trial (Functional Assessment in Elderly Myocardial Infarction Patients With Multivessel Disease) enrolled 1445 older (aged ≥75 years) patients with myocardial infarction and multivessel disease in Italy, Spain, and Poland. Patients were randomized to physiology-guided complete revascularization or treatment of the only culprit lesion. Physiology-guided complete revascularization significantly reduced ischemic adverse events at 1 year. This prespecified analysis investigated the changes between the 2 study groups in angina status, quality of life, physical performance, and frailty. METHODS: Patients underwent validated scales at hospital discharge (baseline) and 1 year later. Angina status was evaluated using the Seattle Angina Questionnaire, health-related quality of life by EQ visual analog scale, physical performance by short physical performance battery, and frailty by the clinical frailty scale. Mixed models for repeated measures analysis were used to study the association between the treatment arms, time, and scales. RESULTS: Baseline and 1-year Seattle Angina Questionnaire, EQ visual analog scale, short physical performance battery, and clinical frailty scale were collected in around two-thirds of the entire FIRE study population. The mean age was 80.9±4.6 years (female sex, 35.9%). Overall, 35.3% were admitted for ST-segment–elevation myocardial infarction, whereas the others were admitted for non–ST-segment–elevation myocardial infarction. Physiology-guided complete revascularization, compared with culprit-only revascularization, was associated with greater improvement in terms of angina status (Seattle Angina Questionnaire summary score, 7.3 [95% CI, 6.1–8.6] points), health-related quality of life (EQ visual analog scale, 6.2 [95% CI, 4.4–8.1] points), and physical performance (short physical performance battery, 1.1 [95% CI, 0.9–1.3] points). After 1 year, patients randomized to culprit-only revascularization experienced a deterioration in frailty status (clinical frailty scale, 0.2 [95% CI, 0.1–0.3] points), which was not observed in patients randomized to physiology-guided complete revascularization. CONCLUSIONS: The present analysis suggested that a physiology-guided complete revascularization is associated with consistent benefits in terms of angina status, quality of life, physical performance, and the absence of further deterioration of the frailty status. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03772743.